Compositions for modulating expression of C9ORF72 antisense transcript
US10793855B2 · kind B2 · utility
1Cited by
189References
42Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 6, 2016 |
| Grant date | Oct 6, 2020 |
| Priority date | — |
| Expiry date | Jan 6, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/31
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compositions and methods for reducing expression of C9ORF72 antisense transcript in an animal with C9ORF72 antisense transcript specific inhibitors. Such methods are useful to treat, prevent, or ameliorate neurodegenerative diseases in an individual in need thereof. Such C9ORF72 antisense transcript specific inhibitors include antisense compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.